Objective:

To investigate the relationship between albumin-to-creatinine ratio (ACR) and mortality in U.S. adults with metabolic dysfunction-associated steatotic liver disease (MASLD) and to explore ACR's mediating role in linking diabetes and hypertension to mortality, specifically hypothesizing that elevated ACR correlates with increased mortality risk.

Key Findings:

• Elevated ACR is associated with increased risk of all-cause and cardiovascular mortality in MASLD patients, suggesting ACR's role as a critical biomarker.
• ACR mediates the relationship between diabetes and hypertension and mortality outcomes, indicating potential pathways for intervention.
• The study highlights the importance of ACR as a biomarker for systemic metabolic risk in MASLD, with implications for clinical risk assessment.

Interpretation:

The findings suggest that ACR is a significant predictor of mortality in adults with MASLD and may serve as a useful clinical tool for risk stratification in this population.

Limitations:

• The study is observational and cannot establish causation, which limits the interpretation of the findings.
• Potential biases in self-reported data and missing information may affect results, particularly in the context of comorbidities.
• The definitions of MASLD may vary, impacting the generalizability of findings to broader populations.

Conclusion:

ACR is a valuable prognostic marker in MASLD, linking metabolic dysfunction to mortality, which could inform clinical management strategies and improve patient outcomes.